Novartis

NVSNYSE Switzerland Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$269.584 B

$141.28 +0.21%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

1,908,151,679

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#3AbbVieABBV$468.7B
#4Merck & Co.MRK$372.3B
#5NovartisNVS$269.6B
#6AstrazenecaAZN$261.1B
#7Abbott LaboratoriesABT$179.4B

What if Novartis were worth as much as…

Open the what-if tool →

Gold $30.2T

$15,844.64

Per share 112× higher

Bitcoin $1.74T

$912.74

Per share 6.46× higher

Nvidia $5.52T

$2,890.63

Per share 20.5× higher

Or at a round number

$500.0B $1.00T $2.00T $5.00T

Where these numbers come from

Share counts and financials for Novartis are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.